• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 455/03 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberineAlkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberineAlkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine

Patent holdings for IPC class C07D 455/03

Total number of patents in this class: 150

10-year publication summary

12
8
9
6
7
10
12
12
9
12
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Shenzhen HighTide Biopharmaceutical, Ltd.
57
13
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
823
9
Nanjing Shijiang Medicine Technology Co., Ltd
26
7
Institute of Materia Medica, Chinese Academy of Medical Sciences
177
5
SpecGx LLC
183
5
Shanghai Shijiang Biotechnology Co., Ltd
8
5
CVI Pharmaceuticals Limited
10
4
Merck Patent GmbH
5831
3
China Pharmaceutical University
299
3
Topharman Shanghai Co., Ltd.
54
3
Centre National de La Recherche Scientifique
10418
2
FUJIFILM Corporation
29367
2
Beijing Tide Pharmaceutical Co. Ltd.
92
2
Changzhou Deze Medical Science Co., Ltd
3
2
Dalian Institute of Chemical Physics, Chinese Academy of Sciences
674
2
Harbin Medisan Pharmaceutical Co., Ltd.
16
2
LMS Co., Ltd.
241
2
Mallinckrodt LLC
132
2
Tongji University
507
2
Universite Claude Bernard Lyon 1
1023
2
Other owners 73